Gene Editing and the Future of Human Health

Starts

May 8, 2019

Ends

May 8, 2019

Location

NYSCF Research Institute


Join NYSCF and the Johns Hopkins Berman Institute of Bioethics for an interactive discussion featuring Johns Hopkins’ Jeffrey Kahn, PhD, MPH, NYSCF CEO Susan L. Solomon, and other bioethics thought leaders to explore the implications of genome editing for research, medicine, and humanity. CRISPR technology has revolutionized biology by allowing researchers to correct genetic mutations that cause disease, and at this event, the panel will discuss the ethical issues that must be considered as gene editing advances into the clinic.

Support for this event was provided by